BridgeMD
New treatment option for Acute Kidney Injury
Official title Comparison of RCA and RACD in Extra-renal Purification by SLED
ClinicalTrials.gov ID: NCT04968587
What this study is testing
- What it's testing
- One of the main RRT issues is anticoagulation of the ECC, because blood contact with biomaterials causes bio-incompatibility reactions, including activation of the coagulation cascade. Based on Regional Citrate Anticoagulation (RCA) protocols, an ionized calcium (Ca-ion) concentration around 0.25 to 0.35mmol / L prevents fibrino formation and allows anticoagulation for the ECC.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- All patient requiring Renal replacement Therapy
You likely can't join if
- Age \< 18 years
- Pregnancy
- Hypercalcemia ≥ 3 mmol/L.
- Major under guardianship
- Major deprived of freedom
- Impossible to obtain free and informed consent
See the full eligibility criteria
- All patient requiring Renal replacement Therapy
- Age \< 18 years
- Pregnancy
- Hypercalcemia ≥ 3 mmol/L.
- Major under guardianship
- Major deprived of freedom
- Impossible to obtain free and informed consent
- Presence of hemostasis or coagulation disorders:
- Thrombocytopenia \< 30 G/L.
- Curative anticoagulation.
- Severe liver disease with Prothrombin rate \<30%.
- Coagulation factor deficit.
- Not registered to a social security system.
The study team makes the final eligibility decision.
Where it's taking place
- Melun, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Melun, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.